These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9818741)

  • 1. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
    Davey KG; Szekely A; Johnson EM; Warnock DW
    J Antimicrob Chemother; 1998 Oct; 42(4):439-44. PubMed ID: 9818741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
    Davey KG; Holmes AD; Johnson EM; Szekely A; Warnock DW
    J Clin Microbiol; 1998 Apr; 36(4):926-30. PubMed ID: 9542910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
    Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
    J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
    Pfaller MA; Barry AL
    J Clin Microbiol; 1994 Aug; 32(8):1992-6. PubMed ID: 7989555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method.
    López-Jodra O; Torres-Rodríguez JM; Méndez-Vásquez R; Ribas-Forcadell E; Morera-López Y; Baró-Tomás T; Alia-Aponte C
    J Antimicrob Chemother; 2000 May; 45(5):645-9. PubMed ID: 10797087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
    Barchiesi F; Colombo AL; McGough DA; Rinaldi MG
    J Clin Microbiol; 1994 Oct; 32(10):2494-500. PubMed ID: 7814488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
    Chen SC; O'Donnell ML; Gordon S; Gilbert GL
    J Antimicrob Chemother; 1996 Feb; 37(2):265-73. PubMed ID: 8707736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.
    Espinel-Ingroff A; Kerkering TM; Goldson PR; Shadomy S
    J Clin Microbiol; 1991 Jun; 29(6):1089-94. PubMed ID: 1864923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):113-7. PubMed ID: 15474320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
    Pfaller MA; Messer SA; Bolmström A; Odds FC; Rex JH
    J Clin Microbiol; 1996 Jul; 34(7):1691-3. PubMed ID: 8784571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of a new method for antifungal drugs susceptibility testing to yeasts].
    Ishigaki S; Kawakami S; Ono Y; Miyazawa Y
    Kansenshogaku Zasshi; 2000 Mar; 74(3):221-30. PubMed ID: 10783576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
    Colombo AL; Barchiesi F; McGough DA; Rinaldi MG
    J Clin Microbiol; 1995 Mar; 33(3):535-40. PubMed ID: 7751353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
    Pfaller MA; Arikan S; Lozano-Chiu M; Chen Y; Coffman S; Messer SA; Rennie R; Sand C; Heffner T; Rex JH; Wang J; Yamane N
    J Clin Microbiol; 1998 Sep; 36(9):2609-12. PubMed ID: 9705401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
    Bernal S; Aller AI; Chávez M; Valverde A; Serrano C; Gutiérrez MJ; Quindós G; Martín Mazuelos E
    Chemotherapy; 2002 Mar; 48(1):21-5. PubMed ID: 11901252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
    Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ
    J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.